
Lyudmila Bazhenova, MD, discusses the FDA’s expanded approval of taletrectinib for ROS1-positive non–small cell lung cancer.
Peers & Perspectives in Oncology
In separate, live events, Sandip P. Patel, MD; David P. Carbone, MD, PHD; and their event participants considered treatment options for a patient with metastatic non–small cell lung cancer.
Case Summary
Presenting symptoms
Physical examination findings
Radiologic findings
Pertinent lab work
CASE UPDATE
about 1 year ago
Breaking Trial Barriers Through Community-Inclusive Researchabout 1 year ago
How to Respond to Toxicities of Each Combination HCC Regimenover 1 year ago
Tagraxofusp Yields Deep Responses as Frontline BPDCN Therapy